These above studies insinuate that one of the key mechanisms via which the SP/NK-1R system (that is overexpressed in cancer) may contribute to osteosarcoma pathogenesis is via activating NK-1R, thereby leading to SP-induced osteosarcoma cell proliferation and prevention of apoptosis. Here, TACR1 is linked to osteosarcoma.